These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26984343)

  • 1. Anti-Mullerian hormone levels do not predict response to pulsatile GnRH in women with hypothalamic amenorrhea.
    Billington EO; Corenblum B
    Gynecol Endocrinol; 2016 Sep; 32(9):728-732. PubMed ID: 26984343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between pulsatile GnRH therapy and gonadotropins for ovulation induction in women with both functional hypothalamic amenorrhea and polycystic ovarian morphology.
    Dumont A; Dewailly D; Plouvier P; Catteau-Jonard S; Robin G
    Gynecol Endocrinol; 2016 Dec; 32(12):999-1004. PubMed ID: 27258574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
    Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
    J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B; Young J; Brailly S; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does polycystic ovarian morphology influence the response to treatment with pulsatile GnRH in functional hypothalamic amenorrhea?
    Dumont A; Dewailly D; Plouvier P; Catteau-Jonard S; Robin G
    Reprod Biol Endocrinol; 2016 Apr; 14(1):24. PubMed ID: 27129705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and functional hypothalamic amenorrhea: a systematic review of the literature and a meta-analysis.
    Tranoulis A; Laios A; Pampanos A; Yannoukakos D; Loutradis D; Michala L
    Fertil Steril; 2018 Apr; 109(4):708-719.e8. PubMed ID: 29605411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous administration of pulsatile gonadotropin-releasing hormone in hypothalamic amenorrhea: effects of dosage.
    Santoro N; Wierman ME; Filicori M; Waldstreicher J; Crowley WF
    J Clin Endocrinol Metab; 1986 Jan; 62(1):109-16. PubMed ID: 3079597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsatile intravenous GnRH treatment in hypothalamic amenorrhea.
    Agrifoglio V; Alaimo G
    Acta Eur Fertil; 1991; 22(6):333-4. PubMed ID: 1844196
    [No Abstract]   [Full Text] [Related]  

  • 10. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders.
    Saffan D; Seibel MM
    Fertil Steril; 1986 Apr; 45(4):475-82. PubMed ID: 3082681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ovulation induction by pulsatile GnRH therapy in 2014: literature review and synthesis of current practice].
    Gronier H; Peigné M; Catteau-Jonard S; Dewailly D; Robin G
    Gynecol Obstet Fertil; 2014 Oct; 42(10):732-40. PubMed ID: 25245838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ovulation induction by pulsatile intravenous administration of Gn-RH to patients with hypothalamic amenorrhea].
    Dessole S; Germond M; Senn A; Welti H; De Grandi P
    Minerva Ginecol; 1993 Mar; 45(3):71-6. PubMed ID: 8332281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovulation induction with pulsatile gonadotropin-releasing hormone (GnRH) or gonadotropins in a case of hypothalamic amenorrhea and diabetes insipidus.
    Georgopoulos NA; Markou KB; Pappas AP; Protonatariou A; Vagenakis GA; Sykiotis GP; Dimopoulos PA; Tzingounis VA
    Gynecol Endocrinol; 2001 Dec; 15(6):421-5. PubMed ID: 11826765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.
    Tal R; Seifer DB; Khanimov M; Malter HE; Grazi RV; Leader B
    Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of ovulation with pulsatile luteinising hormone releasing hormone.
    Mason P; Adams J; Morris DV; Tucker M; Price J; Voulgaris Z; Van der Spuy ZM; Sutherland I; Chambers GR; White S
    Br Med J (Clin Res Ed); 1984 Jan; 288(6412):181-5. PubMed ID: 6419847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective, randomized comparison between pulsatile GnRH therapy and combined gonadotropin (FSH+LH) treatment for ovulation induction in women with hypothalamic amenorrhea and underlying polycystic ovary syndrome.
    Dubourdieu S; Fréour T; Dessolle L; Barrière P
    Eur J Obstet Gynecol Reprod Biol; 2013 May; 168(1):45-8. PubMed ID: 23298894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
    Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea.
    Martin KA; Hall JE; Adams JM; Crowley WF
    J Clin Endocrinol Metab; 1993 Jul; 77(1):125-9. PubMed ID: 8325934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist-treated oocyte donors.
    Polyzos NP; Stoop D; Blockeel C; Adriaensen P; Platteau P; Anckaert E; Smitz J; Devroey P
    Reprod Biomed Online; 2012 May; 24(5):532-9. PubMed ID: 22417669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology.
    Hager M; Ott J; Marschalek J; Marschalek ML; Kinsky C; Marculescu R; Dewailly D
    Reprod Biol Endocrinol; 2022 Jul; 20(1):98. PubMed ID: 35787707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.